Next Article in Journal
Matrix Metalloproteinases: The Gene Expression Signatures of Head and Neck Cancer Progression
Next Article in Special Issue
Genetic Interactions of STAT3 and Anticancer Drug Development
Previous Article in Journal
The Role of Matrix Metalloproteinases in Colorectal Cancer
Previous Article in Special Issue
Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance
Article Menu

Export Article

Open AccessReview

STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications

Department of Neurosurgery, The Johns Hopkins University School of Medicine, 600 N. Wolfe St., Phipps Building Rm 123, Baltimore, MD 21287, USA
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2014, 6(1), 376-395;
Received: 16 December 2013 / Revised: 19 January 2014 / Accepted: 29 January 2014 / Published: 10 February 2014
(This article belongs to the Special Issue STAT3 Signalling in Cancer: Friend or Foe)
PDF [398 KB, uploaded 10 February 2014]


Signal transducer and activator of transcription 3 (STAT3) is a potent regulator of gliomagenesis through its induction of angiogenesis, host immunosuppression, and tumor invasion. Gain of function mutations result in constitutive activation of STAT3 in glioma cells, making STAT3 an attractive target for inhibition in cancer therapy. Nevertheless, some studies show that STAT3 also participates in terminal differentiation and apoptosis of various cell lines and in glioma with phosphatase and tensin homolog (PTEN)-deficient genetic backgrounds. In light of these findings, the utility of STAT3 as a prognostic indicator and as a target of drug therapies will be contingent on a more nuanced understanding of its pro- and anti-tumorigenic effects. View Full-Text
Keywords: glioblastoma; STAT3; immunotherapy glioblastoma; STAT3; immunotherapy

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Kim, J.E.; Patel, M.; Ruzevick, J.; Jackson, C.M.; Lim, M. STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications. Cancers 2014, 6, 376-395.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top